It may have begun as trouble sleeping, a decline in interest in previously effortless activities, a low murmur of unease with no apparent cause. Maybe you’ve caught yourself wondering whether this is just a rough patch, or something that has an actual name -and whether it’s serious enough to see someone, or something you’re supposed to be able to push through on your own.
That uncertainty is one of the hardest parts of early anxiety or depression, and it’s an incredibly common place to be standing. Somewhere in the middle of trying to figure it out, most people run into the same piece of advice, repeated so often it starts to feel almost hollow. “Exercise helps”, it’s said so casually that it’s fair to wonder if it’s actually true, or just something people say because it sounds responsible.
It turns out to be genuinely true – but the honest version of that answer is more specific and more useful. Whether you’re trying to understand what you’re feeling for the first time, weighing exercise against medication, or already on medication and wondering what else might help, this is what the actual research says, not what gets repeated secondhand.
First: How Do You Know If This Is Anxiety or Depression?
There are recognised signs clinicians look for, and knowing them can at least help you decide whether it’s worth talking to someone.
For depression, mental health professionals commonly look for a persistent low mood or loss of interest in things you used to enjoy, lasting most of the day, nearly every day, for two weeks or more – alongside changes in sleep, appetite, energy, concentration, or a sense of worthlessness that doesn’t match the situation. For anxiety, it’s less about a single scary moment and more about excessive worry that’s hard to control, showing up most days for six months or more, often paired with restlessness, fatigue, muscle tension, or sleep trouble.
Two things are worth knowing here. First, mild situational stress that responds to rest, time, or a change in circumstances is different from a clinical pattern – most people go through rough patches that pass without ever meeting criteria for a diagnosis. Second, if what you’re feeling is significantly affecting your work, relationships, or ability to function day to day, or if it includes thoughts of hopelessness or self-harm, that’s a signal to speak with a doctor or mental health professional directly.
Self-Screening Tools Worth Knowing About
None of these replaces a clinical evaluation, but they’re the same starting points many doctors and therapists actually use, and working through one yourself can help you describe what you’re experiencing more precisely when you do talk to someone.
1. PHQ-9 (Patient Health Questionnaire-9)
A 9-item, widely used screening tool for depression severity, based on how often you’ve experienced symptoms like low mood, low energy, or trouble concentrating over the past two weeks.
2. GAD-7 (Generalised Anxiety Disorder-7)
A 7-item tool measuring how often excessive worry and related symptoms have shown up over the past two weeks, commonly used as a first-line anxiety screener in primary care.
3. DASS-21 (Depression, Anxiety, and Stress Scale)
A 21-item self-report tool, developed by Syd Lovibond and Peter Lovibond, that measures the severity of three related but distinct emotional states – depression, anxiety, and stress – as three separate subscales rather than one combined score. It asks how much each symptom (things like dysphoria, autonomic arousal, or nervous tension) applied to you over the past week, rated on a 0–3 scale. What makes it useful is the separation: someone might score high on the stress subscale but low on depression, or the reverse, which can point toward a different focus for support than a single combined score would suggest.
4. K10 (Kessler Psychological Distress Scale)
A shorter, 10-item tool often used in general population screening to flag overall psychological distress, useful as a quick check-in rather than a detailed breakdown.
All four are free, publicly available, and take under ten minutes. None of them diagnoses anything on their own – they’re designed to flag patterns worth discussing with a professional, not to hand you a conclusion.
With that groundwork in place, here’s where exercise actually fits into the picture – for people managing a diagnosed condition, and for people who are still figuring out where they stand.
Type your paragraph here
What the Research Actually Found
In 2023, a team led by Dr Ben Singh at the University of South Australia published the most comprehensive review of its kind in the British Journal of Sports Medicine, integrating 97 systematic reviews, over 1,000 trials, and data from 128,000 individuals. Their conclusion: physical activity resulted in moderate but significant improvements in depression, anxiety, and psychological distress, particularly in individuals with depression, pregnant and postpartum women, and those with HIV or kidney disease.
A follow-up review, published in the same journal in early 2026 by Neil Munro and colleagues, went further – synthesising data across 72 meta-analyses and thousands of randomised trials, and reported that exercise was at least as effective-and at times more so-than standard medication and talk therapy for reducing depression and anxiety symptoms. (ScienceDaily summary)
That’s a striking claim, and it made headlines fast. It’s also where you need to slow down before drawing your own conclusions.
The key to living well in a high-tech world is to spend much less time using technology
The Part the Headlines Left Out
When that 2026 review came out, independent statisticians reviewed it publicly through the UK’s Science Media Centre – and several pushed back hard on the “as good as or better than medication” framing. Their core objection was that the paper compared exercise’s effect size to general benchmarks from separate medication and therapy research, rather than running actual head-to-head statistical comparisons within the same populations. That’s a meaningfully different, weaker kind of evidence than a direct trial pitting exercise against a specific drug in the same group of people.
This doesn’t mean the exercise research is wrong. It means the “better than antidepressants” headline oversold what the data can actually support. Real head-to-head trials do exist, though, and they tell a more nuanced, still-encouraging story.
The Trial That Actually Compared Exercise to a Real Antidepressant
Back in 1999, researchers at Duke University ran what’s now a well-known study (informally called SMILE) that involved 156 older adults with major depression who were split into three groups – one took sertraline, one exercised, and one did both. After 16 weeks, all three groups showed similar improvement. Exercise alone worked about as well, in this trial, as medication alone.
The more interesting finding came six months later. Patients who kept exercising after the study ended were significantly less likely to relapse than those who didn’t – researchers found that for every additional 50 minutes of exercise per week, relapse risk dropped by roughly half. Oddly, the group combining medication and exercise didn’t outperform the exercise-only group at follow-up, which surprised even the researchers, who’d expected an additive effect.
That’s not “exercise beats medicine.” It’s closer to: exercise, sustained over time, may be unusually good at keeping symptoms from coming back – which is a different, and in some ways more useful, question than which treatment “wins” in the first 16 weeks. (today.duke.edu)
Why This Might Actually Be Happening in the Body
Nobody claims to fully understand this, and be wary of anyone who tells you otherwise with total confidence. But several mechanisms show up repeatedly in the research as likely contributors:
- Regulation of brain chemistry. Exercise appears to influence the same serotonin and norepinephrine pathways that SSRIs and SNRIs target directly.
- BDNF production. Physical activity increases brain-derived neurotrophic factor, a protein linked to mood regulation and neuroplasticity – the brain’s ability to adapt and rebuild.
- Lower inflammation. Chronic low-grade inflammation is increasingly tied to depression, and regular movement tends to reduce inflammatory markers over time.
- Better sleep architecture. Exercise, especially earlier in the day, tends to improve sleep quality, and poor sleep is both a symptom and a driver of anxiety and depression.
- A sense of agency. This one’s less biochemical and more psychological: showing up for a workout, especially on a hard day, appears to rebuild a person’s sense of control over their own life – something depression specifically erodes.
The Honest Answer to "Should I Replace My Medicine With Exercise?"
No – not unilaterally, and not without your prescribing doctor in the conversation. This is the part of the story that gets lost when research headlines get compressed into hot takes.
If you’re currently on medication for anxiety or depression, stopping it suddenly – even if you’re feeling genuinely better – carries real risk. Mayo Clinic and most clinical guidance are consistent on this: abrupt discontinuation can trigger withdrawal-like symptoms and meaningfully raises the risk of relapse, and any tapering should be done gradually, under medical supervision. The research on exercise is genuinely encouraging, but it was never designed to tell any individual person “stop your prescription.” It was designed to ask a broader, population-level question: does physical activity help, and how much?
For a lot of people, the more accurate takeaway isn’t “exercise instead of medicine.” It’s “exercise alongside medicine,” or for milder symptoms, “exercise as a legitimate first thing to try before or alongside other treatment,” in conversation with a doctor who knows your specific history, severity, and risk factors – something no general-audience article, however well-researched, can assess on your behalf.
What "Enough Exercise" Actually Looked Like in the Research
If you’re wondering what dose of movement these studies are even talking about, it’s less extreme than most people assume:
- Most benefit was observed with moderate aerobic activity – brisk walking, cycling, swimming – for roughly 150 minutes a week, in line with general WHO physical activity guidelines.
- Shorter programs, 12 weeks or less, showed some of the strongest short-term effects – meaning benefits can show up faster than many people expect.
- Group or supervised settings appeared to help more than solo workouts for depression specifically, hinting that the social component isn’t incidental – it’s doing real work.
- For anxiety, shorter, lower-intensity programs tended to perform best, which is worth knowing if the idea of an intense workout feels like one more thing to dread on a hard day.
The Bottom Line
Starting medication doesn’t mean movement has nothing left to offer. Already exercising and still struggling doesn’t mean you’ve failed at anything – it means your symptoms may need a different or additional tool, and that’s a conversation for a doctor, not a personal failing to sit with alone. These aren’t competing choices to pick between; the research increasingly suggests they’re allies, not rivals. Healing rarely comes from one clean intervention – it tends to come from a few things working together, adjusted over time, with a clinician who’s actually paying attention to how you’re doing.
Sources
- Singh B, Olds T, Curtis R, et al. “Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews.” British Journal of Sports Medicine, 2023. ScienceDaily summary
- Munro NR, Teague S, Somoray K, et al. “Effect of exercise on depression and anxiety symptoms: systematic umbrella review with meta-meta-analysis.” British Journal of Sports Medicine, 2026. BMJ Group summary
- Science Media Centre, “Expert reaction to meta-analysis on exercise and treating depression/anxiety” (independent statistical critique of the 2026 review): sciencemediacentre.org
- Blumenthal JA, Babyak MA, Doraiswamy PM, et al. “Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder” (Duke SMILE trial). Psychosomatic Medicine, 2007; and Duke University summary of the original and follow-up findings: today.duke.edu
- Psychology Today, “Is Exercise as Effective as Medications or Talk Therapy?” (accessible summary of effect sizes): psychologytoday.com
- Mayo Clinic, guidance on tapering and not stopping antidepressants without medical supervision: mayoclinic.org
- American Psychiatric Association / DSM-5-aligned criteria summaries and screening tools (PHQ-9 for depression, GAD-7 for anxiety), as commonly referenced in primary care and psychiatric practice
- Lovibond, S.H. & Lovibond, P.F. “Manual for the Depression Anxiety Stress Scales” (DASS-21), 2nd ed., 1995 – public-domain instrument, scoring reference: arc.psych.wisc.edu
- Kessler RC, et al. Kessler Psychological Distress Scale (K10) – widely used general-population distress screening tool
